Changes in rules of conduct regarding covid-19
The Public Health Agency of Sweden changes the rules of conduct with regards to staying home from work or school if you or someone in your household is ill. This is to reduce...
About the Covid-19 vaccination programme
According to plan, Sweden's Covid-19 vaccination programme could begin as early as January 2021.
Changed recommendations to stay at home with respiratory infection symptoms
After 1 November, those who are fully vaccinated, or who have recently had Covid-19 can return to work or school without being tested, reports the Public Health Agency of Sweden...
Fifth dose of the vaccine for the elderly and at-risk groups
The COVID-19 pandemic is not over. In Sweden, we need to be prepared for an increased spread of COVID-19 during the coming autumn and winter season, writes the Public Health...
Pfizer/Biontech vaccine recommended for children
The Public Health Agency of Sweden recommends that children aged 12-15 who are to be vaccinated against Covid-19 should only receive Pfizer/Biontech’s Comirnaty vaccine. The...
Proposal for measures to reduce the spread of Covid-19
The Swedish Public Health Agency has developed a proposal for infection control measures that will apply from 1st December. The measures concern how indoor public gatherings and...
Testing for Covid-19 is recommended for everyone with symptoms
From and including 22/11, the Public Health Agency of Sweden recommends that the regions offer testing for Covid-19 of everyone 6 years old and older who have symptoms that may...
New information on covid-19 risk groups
In a new report, the Swedish National Board of Health and Welfare (“Socialstyrelsen”) identifies the groups most at risk of being especially seriously affected if they contract...
Entry ban to Sweden extended
The government has today decided that the entry ban for travel to Sweden from countries both outside and within the EU/EEA will be extended from and including 31 October.
EMA recommends Covid-19 Vaccine AstraZeneca for authorisation in the EU
The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for Covid-19 Vaccine AstraZeneca.